Total Payments
$4,477
2024 Payments
$1,514
Companies
11
Transactions
59
Medicare Patients
59
Medicare Billing
$8,082
Payment Breakdown by Category
Food & Beverage$4,477 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,477 | 59 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $1,365 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $717.80 | 9 | $0 (2024) |
| ABBVIE INC. | $681.76 | 12 | $0 (2024) |
| Alkermes, Inc. | $497.73 | 7 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $465.38 | 5 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $269.03 | 2 | $0 (2024) |
| Axsome Therapeutics, Inc. | $121.99 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $121.86 | 1 | $0 (2024) |
| Indivior Inc. | $113.06 | 5 | $0 (2024) |
| ITI, Inc. | $107.70 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,514 | 26 | Janssen Pharmaceuticals, Inc ($343.11) |
| 2023 | $779.05 | 9 | Teva Pharmaceuticals USA, Inc. ($481.24) |
| 2022 | $801.97 | 9 | Alkermes, Inc. ($347.65) |
| 2021 | $1,382 | 15 | Teva Pharmaceuticals USA, Inc. ($495.00) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.45 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $149.99 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/04/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $105.39 | General |
| Category: CNS | ||||||
| 09/28/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Neuroscience | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $119.04 | General |
| 09/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $1.39 | General |
| Category: Neuroscience | ||||||
| 09/18/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: Neuroscience | ||||||
| 09/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Central Nervous System | ||||||
| 09/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: Central Nervous System | ||||||
| 09/11/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $115.93 | General |
| Category: Neurology | ||||||
| 08/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $30.33 | General |
| Category: Neuroscience | ||||||
| 08/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: Neuroscience | ||||||
| 07/25/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Central Nervous System | ||||||
| 05/17/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $128.04 | General |
| Category: Neuroscience | ||||||
| 05/15/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: BH | ||||||
| 04/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.92 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: BH | ||||||
| 04/02/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $121.86 | General |
| Category: PSYCHIATRY | ||||||
| 03/26/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: BH | ||||||
| 03/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.66 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $97.22 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/06/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/01/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: BH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 47 | 94 | $20,419 | $6,258 |
| 2022 | 1 | 12 | 69 | $5,907 | $1,824 |
Total Patients
59
Total Services
163
Medicare Billing
$8,082
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 57 | $8,132 | $3,053 | 37.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 20 | $8,152 | $1,925 | 23.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 13 | 17 | $4,136 | $1,280 | 31.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 69 | $5,907 | $1,824 | 30.9% |
About Jacqueline Werner
Jacqueline Werner is a Psychiatric/Mental Health healthcare provider based in Kapolei, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/18/2019. The National Provider Identifier (NPI) number assigned to this provider is 1720624448.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jacqueline Werner has received a total of $4,477 in payments from pharmaceutical and medical device companies, with $1,514 received in 2024. These payments were reported across 59 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($4,477).
As a Medicare-enrolled provider, Werner has provided services to 59 Medicare beneficiaries, totaling 163 services with total Medicare billing of $8,082. Data is available for 2 years (2022–2023), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health
- Location Kapolei, HI
- Active Since 11/18/2019
- Last Updated 11/19/2020
- Taxonomy Code 163WP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720624448
Products in Payments
- AUSTEDO (Drug) $724.34
- VRAYLAR (Drug) $681.76
- INVEGA SUSTENNA (Drug) $592.80
- INGREZZA (Drug) $465.38
- Austedo XR (Drug) $415.14
- UZEDY (Drug) $225.15
- ARISTADA (Drug) $199.52
- LYBALVI (Drug) $150.08
- COBENFY (Drug) $149.99
- VIVITROL (Drug) $148.13
- SPRAVATO (Drug) $125.00
- Auvelity (Drug) $121.99
- ABILIFY MAINTENA (Drug) $121.86
- PERSERIS (Drug) $113.06
- CAPLYTA (Drug) $107.70
- REXULTI (Drug) $16.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.